SCHEMBL709477

SCHEMBL709477

COC(=O)c1cc2ccc(F)cc2c(OS(=O)(=O)C(F)(F)F)c1C

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 4/20 0.40
DHODH Q02127 1/20 0.39
PTGDR2 Q9Y5Y4 9/20 0.39
HSD11B1 P28845 1/20 0.38
HPGD P15428 2/20 0.37
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
NPC1 O15118 1/20 0.36
CASP3 P42574 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
SENP8 Q96LD8 1/20 0.36
SENP7 Q9BQF6 1/20 0.36
SENP6 Q9GZR1 1/20 0.36
PDK2 Q15119 1/20 0.35
EPAS1 Q99814 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL709904 0.81 PTGDR2 (0.46) PTGDR2
SCHEMBL710259 0.79 PLA2G2A (0.41) PLA2G2ADHODHHPGDKDM4EALDH1A1
SCHEMBL2169838 0.79 PTGDR2 (0.56) PTGDR2
SCHEMBL27822164 0.76 DHODH (0.47) PLA2G2ADHODHHPGDKDM4EALDH1A1
SCHEMBL708470 0.76 PLA2G2A (0.51) PLA2G2ADHODHHPGDKDM4EALDH1A1
SCHEMBL709344 0.76 KMT2A (0.46) PLA2G2ADHODHHPGDKDM4EALDH1A1
SCHEMBL709762 0.75 PTGDR2 (0.46) PTGDR2
SCHEMBL4634707 0.75 EPAS1 (0.47) PLA2G2AHSD11B1HPGDKDM4EALDH1A1
SCHEMBL4634289 0.75 FFAR4 (0.52) PLA2G2AKDM4ENPC1CASP3RAB9A
SCHEMBL23302991 0.74 EPAS1 (0.39) HSD11B1HPGDKDM4EALDH1A1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8124629-B2 Naphthylacetic acids HOFFMANN-LA ROCHE INC. (US) 2012-02-28 US disclosed
US-8124629-B2 Naphthylacetic acids HOFFMANN-LA ROCHE INC. (US) 2012-02-28 US disclosed
US-8124629-B2 Naphthylacetic acids HOFFMANN-LA ROCHE INC. (US) 2012-02-28 US disclosed
US-20100137250-A1 NAPHTHYLACETIC ACIDS FIROOZNIA FARIBORZ 2010-06-03 US disclosed
US-20100137250-A1 NAPHTHYLACETIC ACIDS FIROOZNIA FARIBORZ 2010-06-03 US disclosed
US-20100137250-A1 NAPHTHYLACETIC ACIDS FIROOZNIA FARIBORZ 2010-06-03 US disclosed
WO-2010055005-A1 NAPHTHYLACETIC ACIDS F. HOFFMANN-LA ROCHE AG (CH) 2010-05-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100137250-A1 NAPHTHYLACETIC ACIDS HRH2, HRH1, HRH3 PLA2G2A 737/4885DHODH 1244/4885PTGDR2 39/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.